Company

Tarveda Therapeutics, Inc.

Tarveda Therapeutics develops nanotechnology-based cancer therapeutics with a proprietary drug delivery platform, in Watertown.

About

Founded in 2011 and headquartered in Watertown, US, Tarveda Therapeutics, Inc. develops nanotechnology-based therapeutics for cancer treatment through its proprietary drug delivery platform. The company raised USD 30 mn in Series D funding on January 31, 2017, led by Versant Ventures, with additional investment from Flagship Pioneering, +ND Capital, New Enterprise Associates and Novo Holdings. Its total funds raised amount to USD 30 mn, with a current valuation of USD 93.694 mn.

8Funding rounds

5Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in